1. Home
  2. LCUT vs BDTX Comparison

LCUT vs BDTX Comparison

Compare LCUT & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

HOLD

Current Price

$8.38

Market Cap

191.1M

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$1.97

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCUT
BDTX
Founded
1945
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.1M
171.9M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
LCUT
BDTX
Price
$8.38
$1.97
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$5.00
$9.67
AVG Volume (30 Days)
253.5K
2.3M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
2.54%
N/A
EPS Growth
N/A
130.71
EPS
N/A
N/A
Revenue
$647,933,000.00
N/A
Revenue This Year
$3.74
N/A
Revenue Next Year
$1.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$1.60
52 Week High
$9.80
$4.94

Technical Indicators

Market Signals
Indicator
LCUT
BDTX
Relative Strength Index (RSI) 49.90 48.94
Support Level $7.48 $1.60
Resistance Level $9.80 $2.30
Average True Range (ATR) 0.72 0.14
MACD -0.07 0.06
Stochastic Oscillator 45.54 73.40

Price Performance

Historical Comparison
LCUT
BDTX

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S.-based company that designs, sources, and sells branded kitchenware, tableware, and other home solution products used in the home. The company's product portfolio comprises kitchen tools, cutlery, thermometers, cutting boards, spice racks, dinnerware, stemware, flatware, bath scales, thermal beverage ware, food storage, neoprene travel products, etc. These products are marketed under owned or licensed brands like Farberware, KitchenAid, Mikasa, Misto, Taylor, Sabatier, and Pfaltzgraff, among others. The company mainly sells its products directly to retailers and distributors, and a limited selection directly to consumers through its own websites. It has two reportable operating segments: U.S., which derives maximum revenue, and International.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Share on Social Networks: